Comment
doi: 10.1016/j.jsxm.2019.08.010.
Epub 2019 Sep 18.
Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?
Affiliations
- PMID: 31542352
- DOI: 10.1016/j.jsxm.2019.08.010
Item in Clipboard
Comment
Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?
J Sex Med.
2019 Nov.
No abstract available
Comment in
-
Response to Letter to the Editor Regarding "Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?".J Sex Med. 2019 Nov;16(11):1864-1865. doi: 10.1016/j.jsxm.2019.08.023. J Sex Med. 2019. PMID: 31672288 No abstract available.
Comment on
-
The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).J Sex Med. 2019 Aug;16(8):1178-1187. doi: 10.1016/j.jsxm.2019.05.016. J Sex Med. 2019. PMID: 31351659 Clinical Trial.
-
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).J Sex Med. 2019 Aug;16(8):1188-1198. doi: 10.1016/j.jsxm.2019.05.015. J Sex Med. 2019. PMID: 31351660 Clinical Trial.